Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10037017 | 0.88 | SLC1A3 (0.30) | — | |
| SCHEMBL5669777 | 0.83 | — | — | |
| SCHEMBL12563351 | 0.81 | ALDH1A1 (0.32) | — | |
| SCHEMBL16155348 | 0.81 | CYP3A4 (0.32) | CYP3A4 | |
| SCHEMBL12998309 | 0.80 | MME (0.31) | — | |
| SCHEMBL12563352 | 0.80 | TSHR (0.30) | — | |
| SCHEMBL18671069 | 0.78 | SLC1A3 (0.30) | — | |
| SCHEMBL29433597 | 0.78 | SLC1A3 (0.30) | — | |
| SCHEMBL7636697 | 0.77 | SLC1A3 (0.33) | — | |
| SCHEMBL19726626 | 0.77 | SLC1A3 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170231924-A1 | NOVEL ANALGESIC COMPOSITIONS | VAPOGENIX, INC. | 2017-08-17 | — | — | US | disclosed |
| US-9655867-B2 | Analgesic compositions | VAPOGENIX, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-20160022603-A1 | NOVEL ANALGESIC COMPOSITIONS | VAPOGENIX, INC. | 2016-01-28 | — | — | US | disclosed |
| US-8105999-B2 | Disinfecting compositions containing a polymer complex of organic acid | RECKITT BENCKISER INC. (US) | 2012-01-31 | — | — | US | disclosed |
| US-20110152925-A1 | Skin Preparation That Immobilizes Bacteria | KIMBERLY-CLARK WORLDWIDE, INC. | 2011-06-23 | — | — | US | disclosed |
| US-20090312214-A1 | Disinfecting Compositions Containing a Polymer Complex of Organic Acid | RECKITT BENCKISER INC. (US) | 2009-12-17 | — | — | US | disclosed |
| US-7598214-B2 | Disinfecting compositions containing a polymer complex of an organic acid | RECKITT BENCKISER INC. (US) | 2009-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170231924-A1 | NOVEL ANALGESIC COMPOSITIONS | OPRL1, OPRK1, TRPA1 | CYP3A4 1269/4885 |
| US-20090312214-A1 | Disinfecting Compositions Containing a Polymer Complex of Organic Acid | AOC1, C9, POLR1C | CYP3A4 1154/4885 |
| US-20160022603-A1 | NOVEL ANALGESIC COMPOSITIONS | OPRL1, OPRK1, TRPA1 | CYP3A4 1163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.